Intraplacental choriocarcinoma in a term pregnancy: Is serial postpartum hCG assessment necessary?

Intraplacental choriocarcinoma (IC), or choriocarcinoma in situ, is a rare disease on the gestational trophoblastic disease (GTD) spectrum, with <100 case reports available in the literature. We propose that many patients with IC are likely to be missed as the majority of patients do not present...

全面介紹

書目詳細資料
發表在:Gynecologic Oncology Reports
Main Authors: Lila Marshall, Naixin Zhang, Kyla Jorgenson, Leon Metlay, Ashlee Smith
格式: Article
語言:英语
出版: Elsevier 2023-06-01
主題:
在線閱讀:http://www.sciencedirect.com/science/article/pii/S2352578923000656
實物特徵
總結:Intraplacental choriocarcinoma (IC), or choriocarcinoma in situ, is a rare disease on the gestational trophoblastic disease (GTD) spectrum, with <100 case reports available in the literature. We propose that many patients with IC are likely to be missed as the majority of patients do not present with metastases. Currently, there are no standardized protocols in existence for postpartum monitoring of these patients. We present a case of IC identified in the term placenta of a 21-year-old who delivered by primary cesarean due to concern for fetal intolerance of labor. Subsequently, we review the recommendations available on postpartum monitoring of this likely under-diagnosed condition.
ISSN:2352-5789